Welcome to LookChem.com Sign In|Join Free
  • or
Tetraethyl vinylidene phosphonate, min. 97%, is a phosphonate ester chemical compound with a minimum purity of 97%. It contains a phosphorus atom bonded to four ethyl groups and a vinylidene group. Tetraethyl vinylidene phosphonate, min. 97 % is commonly used as a reagent in chemical synthesis and organic reactions, and serves as a building block in the production of various compounds, including pharmaceuticals, agrochemicals, and specialty chemicals. Its high purity makes it suitable for research and industrial applications where precise and reliable results are required.

37465-31-9

Post Buying Request

37465-31-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

37465-31-9 Usage

Uses

Used in Chemical Synthesis:
Tetraethyl vinylidene phosphonate, min. 97% is used as a reagent in chemical synthesis for its ability to participate in various organic reactions, contributing to the formation of desired products.
Used in Pharmaceutical Production:
In the pharmaceutical industry, Tetraethyl vinylidene phosphonate, min. 97% is used as a building block for the production of various pharmaceutical compounds, due to its versatility in organic synthesis and its high purity which ensures reliable results.
Used in Agrochemical Production:
Tetraethyl vinylidene phosphonate, min. 97% is utilized in the agrochemical industry as a key component in the synthesis of various agrochemicals, helping to create effective products for agricultural applications.
Used in Specialty Chemicals:
Tetraethyl vinylidene phosphonate, min. 97 % is also used in the production of specialty chemicals, where its unique properties and high purity are advantageous for creating specific, high-quality products.

Check Digit Verification of cas no

The CAS Registry Mumber 37465-31-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,7,4,6 and 5 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 37465-31:
(7*3)+(6*7)+(5*4)+(4*6)+(3*5)+(2*3)+(1*1)=129
129 % 10 = 9
So 37465-31-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H22O6P2/c1-6-13-17(11,14-7-2)10(5)18(12,15-8-3)16-9-4/h5-9H2,1-4H3

37465-31-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 1,1-bis(diethoxyphosphoryl)ethene

1.2 Other means of identification

Product number -
Other names tetraethyl ethenylidene-1,1-bisphosphonate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:37465-31-9 SDS

37465-31-9Relevant academic research and scientific papers

Design, synthesis, and biological evaluation of novel aminobisphosphonates possessing an in vivo antitumor activity through a γδ-T lymphocytes-mediated activation mechanism

Simoni, Daniele,Gebbia, Nicola,Invidiata, Francesco Paolo,Eleopra, Marco,Marchetti, Paolo,Rondanin, Riccardo,Baruchello, Riccardo,Provera, Stefano,Marchioro, Carla,Tolomeo, Manlio,Marinelli, Luciana,Limongelli, Vittorio,Novellino, Ettore,Kwaasi, Aaron,Dunford, James,Buccheri, Simona,Caccamo, Nadia,Dieli, Francesco

, p. 6800 - 6807 (2008)

A small series of aminobisphosphonates (N-BPs) structurally related to zoledronic acid was synthesized with the aim of improving activity toward activation of human γδ T cells and in turn their in vivo antitumor activity. The absence of the 1-OH moiety, together with the position and the different basicity of the nitrogen, appears crucial for antitumor activity. In comparison to zoledronic acid, compound 6a shows a greater ability to activate γδ T cells expression (100 times more) and a proapoptotic effect that is better than zoledronic acid. The potent activation of γδ T cells, in addition to evidence of the in vivo antitumor activity of 6a, suggests it may be a new potential drug candidate for cancer treatment.

A di(bisphosphonic acid) for protein coupling and targeting to bone

Bansal, Geeti,Gittens, Sebastien A.,Uludag, Hasan

, p. 2788 - 2799 (2004)

Proteins intended for treatment of bone diseases should ideally exhibit a high bone affinity, so that they are preferentially deposited to bones after systemic administration. This can be achieved by combining molecules having a high affinity to bone with

Synthesis of functionalized bisphosphonates via click chemistry

Skarpos, Hanna,Osipov, Sergey N.,Vorob'Eva, Daria V.,Odinets, Irina L.,Lork, Enno,Roeschenthaler, Gerd-Volker

, p. 2361 - 2367 (2007)

An efficient general synthetic approach giving the possibility for facile, rapid and cheap access to a wide range of novel nitrogen-bisphosphonates (N-BPs) as potent drug candidates, based on the reaction of mono- and bis-propargyl-substituted bisphosphon

New synthesis of gem-bis(phosphono)ethylenes and their applications

Inoue, Susumu,Okauchi, Tatsuo,Minami, Toru

, p. 1971 - 1976 (2003)

Palladium-catalyzed cross-coupling reaction of α-phosphonovinyl nonafluorobutanesulfonates (nonaflates) 1 with dialkyl phosphites gave versatile intermediate reagents, gembis(phosphono)ethylenes 2a-d in 35-93% yields. The reaction of bis(diethylphosphono)

(2-Aminobenzothiazole)-Methyl-1,1-bisphosphonic acids: Targeting matrix metalloproteinase 13 inhibition to the bone

Laghezza, Antonio,Piemontese, Luca,Brunetti, Leonardo,Caradonna, Alessia,Agamennone, Mariangela,Loiodice, Fulvio,Tortorella, Paolo

, p. 1 - 14 (2021/02/05)

Matrix Metalloproteinases (MMPs) are a family of secreted and membrane-bound enzymes, of which 24 isoforms are known in humans. These enzymes degrade the proteins of the extracellular matrix and play a role of utmost importance in the physiological remodeling of all tissues. However, certain MMPs, such as MMP-2, -9, and -13, can be overexpressed in pathological states, including cancer and metastasis. Consequently, the development of MMP inhibitors (MMPIs) has been explored for a long time as a strategy to prevent and hinder metastatic growth, but the important side effects linked to promiscuous inhibition of MMPs prevented the clinical use of MMPIs. Therefore, several strategies were proposed to improve the therapeutic profile of this pharmaceutical class, including improved selectivity toward specific MMP isoforms and targeting of specific organs and tissues. Combining both approaches, we conducted the synthesis and preliminary biological evaluation of a series of (2-aminobenzothiazole)-methyl-1,1-bisphosphonic acids active as selective inhibitors of MMP-13 via in vitro and in silico studies, which could prove useful for the treatment of bone metastases thanks to the bone-targeting capabilities granted by the bisphosphonic acid group.

Challenging synthesis of bisphosphonate derivatives with reduced steric hindrance

Chiminazzo, Andrea,Sperni, Laura,Fabris, Fabrizio,Scarso, Alessandro

, (2021/04/12)

An alternative approach is reported for the synthesis of methyl ester protected bisphosphonate building blocks, such as methylene bisphosphonate, vinylidenebisphosphonate and aryl substituted prochiral vinylidenebisphosphonates, that cannot be obtained directly from dimethyl phosphite and dichloromethane.

Modification of Amorphous Mesoporous Zirconia Nanoparticles with Bisphosphonic Acids: A Straightforward Approach for Tailoring the Surface Properties of the Nanoparticles

Hossain, Khohinur,Florean, Luca,Del Tedesco, Anna,Cattaruzza, Elti,Geppi, Marco,Borsacchi, Silvia,Canton, Patrizia,Benedetti, Alvise,Riello, Pietro,Scarso, Alessandro

, p. 17941 - 17951 (2021/11/20)

The use of readily prepared bisphosphonic acids obtained in few steps through a thio-Michael addition of commercially available thiols on tetraethyl vinylidenebisphosphonate enables the straightforward surface modification of amorphous mesoporous zirconia nanoparticles. Simple stirring of the zirconia nanoparticles in a buffered aqueous solution of the proper bisphosphonic acid leads to the surface functionalization of the nanoparticles with different kinds of functional groups, charge and hydrophobic properties. Formation of both chemisorbed and physisorbed layers of the bisphosphonic acid take place, observing after extensive washing a grafting density of 1.1 molecules/nm2 with negligible release in neutral or acidic pH conditions, demonstrating stronger loading compared to monophosphonate derivatives. The modified nanoparticles were characterized by IR, XPS, ζ-potential analysis to investigate the loading of the bisphosphonic acid, FE-SEM to investigate the size and morphologies of the nanoparticles and 31P and 1H MAS NMR to investigate the coordination motif of the phosphonate units on the surface. All these analytical techniques demonstrated the strong affinity of the bisphosphonic moiety for the Zr(IV) metal centers. The functionalization with bisphosphonic acids represents a straightforward covalent approach for tailoring the superficial properties of zirconia nanoparticles, much straightforward compared the classic use of trisalkoxysilane or trichlorosilane reagents typically employed for the functionalization of silica and metal oxide nanoparticles. Extension of the use of bisphosphonates to other metal oxide nanoparticles is advisable.

PHOSPHONATE CONJUGATES AND USES THEREOF

-

Paragraph 0089, (2020/07/31)

Phosphonate conjugates, preferably, bisphosphonate conjugates; methods of inhibiting Ron receptor tyrosine kinase and methods of treatment of bone destruction due to cancer or other conditions utilizing the provided phosphonate conjugates.

C-Alkyl-bis-phosphoryl chelating systems for the potential recovery of strategic metals

Babouri, Rachida,Halidou Dougourikoye, Abdoul Razak,Ilagouma, Amadou TidJani,Pirat, Jean-Luc,Virieux, David,Volle, Jean-No?l

, (2020/09/07)

Methylene-bis-phosphonic acid and derivatives are used as complexing agents, diagnostics, therapeutics and show interesting virustatic properties. We describe the syntheses of mono- and di-substituted bisphosphonates and mono- and disubstituted diethyl ((diphenylphosphoryl)methyl)phosphonate as possible chelating systems for the recovery of strategic metals.

MULTIFUNCTIONAL CONJUGATES

-

, (2019/01/21)

The present invention provides compounds suitable for use in the treatment of conditions where it is beneficial to halt bone loss and kill cancer cells, particularly in metastases to and primary tumours in the bone and surrounding tissues. Consequently the present invention provides compounds comprising a bisphosphonate moiety linked to a phytochemical, pharmaceutical compositions thereof and methods of treatment of bone diseases and/or proliferative disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 37465-31-9